Literature DB >> 27526706

Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias.

Shveta S Motwani1,2, Leal Herlitz3, Divya Monga4, Kenar D Jhaveri5, Albert Q Lam6,2.   

Abstract

Paraproteins are monoclonal Igs that accumulate in blood as a result of abnormal excess production. These circulating proteins cause a diversity of kidney disorders that are increasingly being comanaged by nephrologists. In this review, we discuss paraprotein-related diseases that affect the glomerulus. We provide a broad overview of diseases characterized by nonorganized deposits, such as monoclonal Ig deposition disease (MIDD), proliferative GN with monoclonal Ig deposits (PGNMID), and C3 glomerulopathy, as well as those characterized by organized deposits, such as amyloidosis, immunotactoid glomerulopathy, fibrillary GN, and cryoglobulinemic GN, and rarer disorders, such as monoclonal crystalline glomerulopathies, paraprotein-related thrombotic microangiopathies, and membranous-like glomerulopathy with masked IgGκ deposits. This review will provide the nephrologist with an up to date understanding of these entities and highlight the areas of deficit in evidence and future lines of research.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  Amyloidosis; Immunoglobulin G; Kidney Glomerulus; Paraproteinemias; Paraproteins; Thrombotic Microangiopathies; amyloidosis; cancer; cryoglobulinemia; fibrillary glomerulonephritis; glomerular disease; glomerulonephritis; immunotactoid glomerulopathy; light chain deposition disease; multiple myeloma; nephrotic syndrome

Mesh:

Substances:

Year:  2016        PMID: 27526706      PMCID: PMC5142064          DOI: 10.2215/CJN.02980316

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  117 in total

1.  Proliferative glomerulonephritis with monoclonal immunoglobulin G3κ deposits in association with parvovirus B19 infection.

Authors:  Emiko Fujita; Akira Shimizu; Tomohiro Kaneko; Yukinari Masuda; Chikara Ishihara; Akiko Mii; Seiichiro Higo; Yusuke Kajimoto; Go Kanzaki; Shinya Nagasaka; Yasuhiko Iino; Yasuo Katayama; Yuh Fukuda
Journal:  Hum Pathol       Date:  2012-07-21       Impact factor: 3.466

2.  The combination of thrombotic microangiopathy and nodular sclerosis in light chain deposition disease.

Authors:  Talerngsak Kanjanabuch; Rati Bunruang; Nattachai Srisawat; Songkiat Lewsuwan; Vipawee Kittikovit; Somchai Eiam-Ong
Journal:  J Med Assoc Thai       Date:  2006-08

3.  Brief report: heavy-chain deposition disease.

Authors:  P Aucouturier; A A Khamlichi; G Touchard; E Justrabo; M Cogne; B Chauffert; F Martin; J L Preud'homme
Journal:  N Engl J Med       Date:  1993-11-04       Impact factor: 91.245

4.  Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation.

Authors:  Sandra M S Herrmann; Morie A Gertz; Mark D Stegall; Angela Dispenzieri; Fernando C Cosio; Shaji Kumar; Martha Q Lacy; Patrick G Dean; Mikel Prieto; Steven R Zeldenrust; Francis K Buadi; Stephen J Russell; Scott L Nyberg; Suzanne R Hayman; David Dingli; Fernando C Fervenza; Nelson Leung
Journal:  Nephrol Dial Transplant       Date:  2011-05-04       Impact factor: 5.992

5.  Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H.

Authors:  T S Jokiranta; A Solomon; M K Pangburn; P F Zipfel; S Meri
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

6.  Paraffin immunofluorescence in the renal pathology laboratory: more than a salvage technique.

Authors:  Nidia C Messias; Patrick D Walker; Christopher P Larsen
Journal:  Mod Pathol       Date:  2015-02-13       Impact factor: 7.842

7.  A vasculopathy with deposition of lambda light chain crystals.

Authors:  G C Stone; B A Wall; I R Oppliger; M H Wener; S L Jolly; A Aguirre; R Dwyer; P A Simkin
Journal:  Ann Intern Med       Date:  1989-02-15       Impact factor: 25.391

8.  Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients.

Authors:  Vincent Javaugue; Alexandre Karras; François Glowacki; Brigitte McGregor; Corinne Lacombe; Jean-Michel Goujon; Stéphanie Ragot; Pierre Aucouturier; Guy Touchard; Frank Bridoux
Journal:  Am J Kidney Dis       Date:  2013-06-04       Impact factor: 8.860

9.  Sequences of V kappa L subgroup light chains in Fanconi's syndrome. Light chain V region gene usage restriction and peculiarities in myeloma-associated Fanconi's syndrome.

Authors:  A Rocca; A A Khamlichi; G Touchard; B Mougenot; P Ronco; L Denoroy; S Deret; J L Preud'homme; P Aucouturier; M Cogné
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

10.  Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement.

Authors:  Sanjeev Sethi; Fernando C Fervenza; Yuzhou Zhang; Ladan Zand; Nicole C Meyer; Nicolò Borsa; Samih H Nasr; Richard J H Smith
Journal:  Kidney Int       Date:  2012-12-12       Impact factor: 10.612

View more
  18 in total

Review 1.  Pathophysiology and management of monoclonal gammopathy of renal significance.

Authors:  Ankur Jain; Richard Haynes; Jaimal Kothari; Akhil Khera; Maria Soares; Karthik Ramasamy
Journal:  Blood Adv       Date:  2019-08-13

2.  Paraprotein-Related Kidney Disease: Attack of the Killer M Proteins.

Authors:  Mark A Perazella; Kevin W Finkel
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-07       Impact factor: 8.237

3.  Proliferative glomerulonephritis with unusual microlamellar organized deposits related to monoclonal immunoglobulin G3 (IgG3) kappa.

Authors:  Akiko Mii; Akira Shimizu; Daisuke Takada; Shuichi Tsuruoka
Journal:  CEN Case Rep       Date:  2018-07-09

4.  AKI in a Patient with Fever, Rash, and Joint Pain.

Authors:  Abraham W Aron; Ursula C Brewster
Journal:  Kidney360       Date:  2021-05-27

5.  Optimal conditions and the advantages of using laser microdissection and liquid chromatography tandem mass spectrometry for diagnosing renal amyloidosis.

Authors:  Michiko Aoki; Dedong Kang; Akira Katayama; Naomi Kuwahara; Shinya Nagasaka; Yoko Endo; Mika Terasaki; Shinobu Kunugi; Yasuhiro Terasaki; Akira Shimizu
Journal:  Clin Exp Nephrol       Date:  2018-01-25       Impact factor: 2.801

Review 6.  Dominant C3 glomerulopathy: new roles for an old actor in renal pathology.

Authors:  Nicola Pirozzi; Antonella Stoppacciaro; Paolo Menè
Journal:  J Nephrol       Date:  2017-11-18       Impact factor: 3.902

7.  Thrombotic microangiopathy with intraglomerular IgM pseudothrombi in Waldenström macroglobulinemia and IgM monoclonal gammopathy.

Authors:  Serena Yen Shan Tan; Richard Kent Sibley; Sharina Belani; Sumie Iwasaki; Leonid Yankulin; Tracy Jonelis; John Patrick Twistington Higgins; Neeraja Kambham; Megan Leigh Troxell
Journal:  J Nephrol       Date:  2018-10-17       Impact factor: 3.902

8.  Monoclonal Immunoglobulin-Associated Renal Lesions in Patients with Newly Diagnosed Multiple Myeloma: A Report from a Single Center.

Authors:  Zi-Shan Lin; Xiao-Juan Yu; Xu Zhang; Su-Xia Wang; Xi-Nan Cen; Fu-De Zhou; Ming-Hui Zhao
Journal:  Cancer Manag Res       Date:  2021-05-13       Impact factor: 3.989

Review 9.  Novel Insights into Crystal-Induced Kidney Injury.

Authors:  Shrikant R Mulay; Chongxu Shi; Xiaoyuan Ma; Hans Joachim Anders
Journal:  Kidney Dis (Basel)       Date:  2018-04-03

10.  Clinicopathological characteristics of patients with paraproteinemia and renal damage.

Authors:  Xuanli Tang; Feng Wan; Jin Yu; Xiaohong Li; Ruchun Yang; Bin Zhu
Journal:  Eur J Med Res       Date:  2021-07-03       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.